GlassScriptPhysician profile
Alexander Martin
NPI 1316504236
$3,254.72
in general payments reported to CMS, 2019-2025
23 companies · $2,120 in 2025
The $2,120 reported for 2025 was more than what 81% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $56.31 · 2024: $1,078 · 2025: $2,120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,616 · Travel and Lodging: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,616.41 |
| Travel and Lodging | $638.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,011.78 | 2024-2025 | Aquabeam System |
| Teleflex LLC | $665.77 | 2024-2025 | Urolift |
| Agiliti Surgical, INC. | $443.26 | 2024-2025 | Quanta Cyberblade, Sonablate Hifu, Koelis Trinity Fusion Biopsy System |
| Calyxo, INC. | $250.16 | 2024-2025 | Cvac Aspiration System |
| Tolmar, INC. | $152.48 | 2024-2025 | Jatenzo, Eligard |
| Sumitomo Pharma America, INC. | $115.54 | 2024-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $97.68 | 2024-2025 | General - Female Sui, Rezum Generator, Axonics |
| Abbvie INC. | $68.07 | 2024-2025 | |
| Accord Healthcare, INC. | $61.41 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $50.33 | 2024-2025 | Adstiladrin |
| Endo USA, INC. | $46.01 | 2024-2025 | Xiaflex, Aveed |
| Janssen Biotech, INC. | $45.28 | 2025 | Erleada |
| Verity Pharmaceuticals INC. | $32.86 | 2024-2025 | Trelstar |
| Ambu INC. | $31.48 | 2024 | |
| Medtronic, INC. | $25.49 | 2025 | Interstim |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $25.38 | 2023 | Keytruda, Welireg, Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $23.97 | 2025 | |
| Laborie Medical Technologies Corp. | $22.22 | 2025 | |
| Civco Medical Instruments | $20.55 | 2024 | |
| Azurity Pharmaceuticals, INC. | $19.84 | 2025 | Azmiro |
| Baxter Healthcare | $16.18 | 2023 | Floseal |
| Coloplast Corp | $14.75 | 2023 | Speedicath |
| Axonics, INC. | $14.23 | 2024 | Bulkamid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.